Physician profile
Inderpal Singh
NPI 1902164981
$11,667.23
in general payments reported to CMS, 2019-2025
28 companies · $318 in 2025
The $318 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,659 · 2020: $1,224 · 2021: $2,800 · 2022: $3,390 · 2023: $193 · 2024: $83.24 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $593.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,836.36 | 2019-2020 | |
| Spinal Simplicity, LLC | $2,242.22 | 2021 | |
| Nalu Medical, INC. | $1,649.52 | 2021-2022 | |
| Medtronic, INC. | $1,360.00 | 2021-2025 | Intellis Adaptivestim, Accurian, Inceptiv |
| Vertos Medical, INC. | $832.47 | 2019-2020 | |
| Nevro Corp. | $596.77 | 2019-2022 | |
| Spr Therapeutics, INC | $394.12 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $308.78 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $213.51 | 2019-2022 | |
| Relievant Medsystems, INC. | $208.74 | 2020 | |
| Abbott Laboratories | $203.08 | 2025 | Proclaim, Eterna |
| Electronic Waveform Lab, INC. | $179.17 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $96.35 | 2019-2022 | |
| Carl Zeiss Meditec USA, INC. | $96.14 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $93.21 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $66.62 | 2023-2024 | Na, Wavewriter Alpha Prime 16 |
| Avanos Medical | $49.30 | 2019 | |
| Pfizer INC. | $41.62 | 2019-2020 | |
| Assertio Therapeutics, INC. | $40.42 | 2019 | |
| Daiichi Sankyo INC. | $29.28 | 2019 | |
| Davol INC. | $19.84 | 2021 | |
| Si-Bone, INC. | $19.68 | 2019 | |
| Karl Storz Endoscopy-America | $19.52 | 2019 | |
| Painteq LLC | $16.30 | 2023 | Painteq |
| Forte Bio-Pharma LLC | $15.03 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.81 | 2019 | |
| Virtus Pharmaceuticals LLC | $12.69 | 2021 | |
| Kaleo, INC. | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Inderpal Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.